Ultra-Long-Term Therapy of Benign Essential Blepharospasm with Botulinumtoxin A—30 Years of Experience in a Tertiary Care Center

Ultra-Long-Term Therapy of Benign Essential Blepharospasm with Botulinumtoxin A—30 Years of Experience in a Tertiary Care Center

Aim of this study was to investigate the long-term results of botulinum toxin A (BoNT-A) injections for the treatment of benign essential blepharospasm (BEB) and to report our experience with (ultra-)long-term treatment with onabotulinumtoxin-A. We conducted a retrospective cross-sectional analysis...

Full description

Bibliographic Details
Main Authors: Bettina Wabbels, Rolf Fimmers, Peter Roggenkämper
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Toxins
Subjects:
blepharospasm
botulinum toxin
long-term
outcome
adverse events
Online Access:https://www.mdpi.com/2072-6651/14/2/120

Internet

https://www.mdpi.com/2072-6651/14/2/120

Similar Items